SALTONASE
Live / Applied — Final refusal written — not yet mailed (as of 16 Mar 2024)
What this means for you
Not registered yet, but its 25 Oct 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79359491
- Mark type
- Stylized text
- Filed
- 25 Oct 2022
- Attorney of record
- Stephen T. Olson
Goods and services
- Class 001 — Chemicals: Enzymes derived from biotechnological processes for use in industry; enzymes, other than for medical use, for use in the continuous homogenous isothermal amplifications of specific DNA templates for scientific and research purposes; industrial chemicals; chemicals e.g. reagents, materials, manufacturing process components for use in separation other than medical or veterinary purposes including biotechnological, biochemical, chemical and pharmaceutical catalysts; catalysts for chemical and biochemical processes; enzymes for use as biochemical catalysts for industrial purposes; chemicals used in industry, science and photography, agriculture, horticulture and forestry, namely, chemicals, e.g. reagents, materials, manufacturing process components for the separation and purification of mixtures, and for the isolation of substances; chemical products, namely proteins for use in chromatographic processes, other than for medical purposes; chromatographic chemical materials, namely proteins for the treatment of biopolymers, not for medical treatment; artificial porous unprocessed resins for chromatographic purposes; all the aforesaid goods also provided as part of kits.
- Class 005 — Pharmaceuticals: Ferments for pharmaceutical purposes; enzymes for medical purposes
- Class 042 — Scientific and technological services: Chemical research; chemical analytical examinations, namely executing of chemical analysis, quality control, composition control; chemical analysis; biochemical analysis; laboratory analysis in the field of chemistry; analysis of product development, namely product development consultation, composition confirmations, nucleic acid purification efficacy monitoring, chemical, biotechnological, pharmaceutical manufacturing feasibility testing; biotechnological scientific research relating to enzymatic synthesis; scientific research relating to biotechnology; chemical research; chemical technological research; research and development of biotechnology in the field of chemistry, synthetic biology, biotechnology, pharmacy, diagnostics, food processing; chemical analysis services for use in design; chemical analysis services for use in the testing of material.
Owner
- BLIRT S.A., PL
Prosecution history
- 07 Jun 2024 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 16 Mar 2024 — FINAL REFUSAL WRITTEN
- 28 Feb 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Feb 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 Feb 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Sept 2023 — REFUSAL PROCESSED BY IB
- 31 Aug 2023 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 31 Aug 2023 — REFUSAL PROCESSED BY MPU
- 11 Aug 2023 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 10 Aug 2023 — NON-FINAL ACTION WRITTEN
- 09 Aug 2023 — ASSIGNED TO EXAMINER
- 10 Jan 2023 — APPLICATION FILING RECEIPT MAILED
- 06 Jan 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 05 Jan 2023 — SN ASSIGNED FOR SECT 66A APPL FROM IB